IN2013MU03508A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03508A
IN2013MU03508A IN3508MU2013A IN2013MU03508A IN 2013MU03508 A IN2013MU03508 A IN 2013MU03508A IN 3508MU2013 A IN3508MU2013 A IN 3508MU2013A IN 2013MU03508 A IN2013MU03508 A IN 2013MU03508A
Authority
IN
India
Prior art keywords
linezolid
present
crystalline form
relates
crystallizing
Prior art date
Application number
Other languages
English (en)
Inventor
Pravin Popatrao Ghorpade
Karunesh Kumar Tiwari
Axaykumar Dave
Yogendarkumar Chauhan
Original Assignee
Unimark Remedies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unimark Remedies Ltd filed Critical Unimark Remedies Ltd
Priority to PCT/IB2014/065837 priority Critical patent/WO2015068121A1/en
Priority to IN3508MU2013 priority patent/IN2013MU03508A/en
Publication of IN2013MU03508A publication Critical patent/IN2013MU03508A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN3508MU2013 2013-11-06 2014-11-06 IN2013MU03508A (enExample)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IB2014/065837 WO2015068121A1 (en) 2013-11-06 2014-11-06 Process for preparation of crystalline form i of linezolid and its compositions
IN3508MU2013 IN2013MU03508A (enExample) 2013-11-06 2014-11-06

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3508MU2013 IN2013MU03508A (enExample) 2013-11-06 2014-11-06

Publications (1)

Publication Number Publication Date
IN2013MU03508A true IN2013MU03508A (enExample) 2015-07-24

Family

ID=52144768

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3508MU2013 IN2013MU03508A (enExample) 2013-11-06 2014-11-06

Country Status (2)

Country Link
IN (1) IN2013MU03508A (enExample)
WO (1) WO2015068121A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105566242B (zh) * 2016-01-12 2017-12-05 江苏豪森药业集团有限公司 利奈唑胺及其中间体的制备方法
CN110483431A (zh) * 2019-09-04 2019-11-22 桂林南药股份有限公司 利奈唑胺杂质化合物、其制备方法以及其应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688792A (en) 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
MY115155A (en) 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
HUP0004388A3 (en) 1997-11-07 2001-10-29 Upjohn Co Process for the preparation of oxazolidinones, intermediates and preparation thereof
US6444813B2 (en) 2000-02-02 2002-09-03 Pharmacia & Upjohn Company Linezolid-crystal form II
PT1673370E (pt) 2003-10-16 2009-11-05 Symed Labs Ltd Forma cristalina de linezolida
MX2007000084A (es) 2004-06-29 2007-06-14 Teva Pharma Formas solidas de linezolid y procesos para la preparacion delas mismas.
US7649096B2 (en) 2005-07-15 2010-01-19 Glenmark Pharmaceuticals Limited Process for the preparation of a crystalline form of (S)-N [[3-(3-fluoro-4(4-morpholinyl) phenyl]-2-oxo-5-oxazolidinyl] methyl] acetamide
WO2007026369A1 (en) 2005-08-29 2007-03-08 Symed Labs Limited A novel amorphous form of linezolid
US20070197529A1 (en) 2005-12-01 2007-08-23 Viviana Braude Isolated desfluoro-linezolid, preparation thereof and its use as a reference marker and standard
CN101774978B (zh) 2009-01-13 2011-09-21 联化科技股份有限公司 一种利奈唑胺的制备方法及其中间体
WO2011050826A1 (en) 2009-10-28 2011-05-05 Synthon B.V. Process for making crystalline form a of linezolid
US20130137864A1 (en) 2009-12-26 2013-05-30 Jayaraman Venkat Raman Process for the preparation of linezolid
EP2603505A1 (en) 2010-08-11 2013-06-19 Synthon BV Process for making linezolid
EP2593440A1 (en) 2011-02-24 2013-05-22 Lee Pharma Limited Anhydrous linezolid crystalline form-ii
EP2683696A1 (en) 2011-03-09 2014-01-15 Synthon BV Process for making crystalline form a of linezolid
WO2013072923A1 (en) 2011-09-19 2013-05-23 Cadila Healthcare Limited Process for the preparation of crystalline linezolid
WO2013093751A1 (en) 2011-12-24 2013-06-27 Alembic Pharmaceuticals Limited Packaging for linezolid
WO2013120496A1 (en) 2012-02-14 2013-08-22 Pharmathen S.A. Process for the preparation of linezolid in crystalline form and salts thereof
CN102850290A (zh) 2012-10-10 2013-01-02 天津市炜杰科技有限公司 晶型i型利奈唑胺的制备方法
WO2014101064A1 (zh) * 2012-12-27 2014-07-03 上海创诺医药集团有限公司 一种制备利奈唑胺晶型i的方法

Also Published As

Publication number Publication date
WO2015068121A1 (en) 2015-05-14

Similar Documents

Publication Publication Date Title
IN2015KN00262A (enExample)
MX2021014128A (es) Polimorfos de selinexor.
PH12014000179A1 (en) New pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them
MX2016012419A (es) Formas solidas de ibrutinib y procesos para la produccion de las mismas.
JO3675B1 (ar) مشتقات هيدروكسي إستر جديدة،عملية لتحضيرها وتركيبات صيدلية تحتوي عليها
EA033455B1 (ru) Кристаллические формы замещенных 5-фтор-1h-пиразолопиридинов, способы их получения, их применение для получения лекарственного средства, лекарственное средство и способ лечения на их основе
MX2015009617A (es) Formas cristalinas de acido { [1-ciano-5-(4-clorofenoxi)-4-hidroxi -isoquinolin-3-carbonil]-amino}-acetico.
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
GEP201706760B (en) Novel abexinostate salt, associated crystalline form, preparation method thereof and the pharmaceutical compositions containing same
MY191352A (en) Aldosterone synthase inhibitors
IN2014MU00455A (enExample)
WO2014203275A3 (en) An improved process for the preparation of apixaban and intermediates thereof
PH12018500872A1 (en) Innovative preparation and crystallization of iosimenol
MX2016009667A (es) Forma cristalina alfa del compuesto a monobenzoato y método de preparación de la misma y composición farmacéutica que comprende la misma.
IN2013MU03508A (enExample)
IL245260B (en) Non-aqueous crystalline form of cabazitaxel, process for its preparation and pharmaceutical compositions thereof
TN2015000095A1 (en) Macrolide derivatives, preparation thereof and therapeutic use thereof
IN2013CH04314A (enExample)
TN2013000441A1 (en) 3-spirocyclic piperidine derivatives as ghrelin receptor agonists
IN2013MU02528A (enExample)
IN2013MU02133A (enExample)
IN2013MU02771A (enExample)
MX2016001100A (es) Proceso mejorado para preparar la forma cristalina iv del posaconazol.
IN2013CH05884A (enExample)
IN2013CH05769A (enExample)